JP2023552864A5 - - Google Patents
Info
- Publication number
- JP2023552864A5 JP2023552864A5 JP2023535832A JP2023535832A JP2023552864A5 JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5 JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023535832 A JP2023535832 A JP 2023535832A JP 2023552864 A5 JP2023552864 A5 JP 2023552864A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- formula
- pyridazin
- imidazo
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2019702.6 | 2020-12-14 | ||
| GBGB2019702.6A GB202019702D0 (en) | 2020-12-14 | 2020-12-14 | Therapeutic agents |
| GBGB2109583.1A GB202109583D0 (en) | 2021-07-02 | 2021-07-02 | Therapeutic agents |
| GB2109583.1 | 2021-07-02 | ||
| PCT/EP2021/084448 WO2022128584A1 (en) | 2020-12-14 | 2021-12-06 | Imidazopyridazine derivatives as il-17 modulators |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023552864A JP2023552864A (ja) | 2023-12-19 |
| JP2023552864A5 true JP2023552864A5 (cg-RX-API-DMAC7.html) | 2024-11-15 |
| JP7827725B2 JP7827725B2 (ja) | 2026-03-10 |
Family
ID=79164779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535832A Active JP7827725B2 (ja) | 2020-12-14 | 2021-12-06 | Il-17モジュレータとしてのイミダゾピリダジン誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240140951A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4259631A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7827725B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3200594A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022128584A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201909190D0 (en) * | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| US20240140951A1 (en) * | 2020-12-14 | 2024-05-02 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
| AR126255A1 (es) | 2021-07-01 | 2023-10-04 | UCB Biopharma SRL | Derivados de imidazotriazina como moduladores de il-17 |
| WO2023025783A1 (en) | 2021-08-23 | 2023-03-02 | Leo Pharma A/S | Small molecule modulators of il-17 |
| WO2023111181A1 (en) | 2021-12-16 | 2023-06-22 | Leo Pharma A/S | Small molecule modulators of il-17 |
| EP4486737A1 (en) | 2022-03-04 | 2025-01-08 | LEO Pharma A/S | Small molecule modulators of il-17 |
| GB202210731D0 (en) | 2022-07-22 | 2022-09-07 | UCB Biopharma SRL | Therapeutic agents |
| TW202430165A (zh) | 2022-12-02 | 2024-08-01 | 丹麥商理奧藥品公司 | Il-17之小分子調節劑 |
| WO2024138286A1 (en) * | 2022-12-26 | 2024-07-04 | Usynova Pharmaceuticals, Ltd. | Il-17a modulators |
| CN121487927A (zh) * | 2023-03-14 | 2026-02-06 | 歌礼制药(中国)有限公司 | Il-17a的小分子调节剂、制备方法及其使用方法 |
| EP4688156A1 (en) * | 2023-03-28 | 2026-02-11 | Janssen Pharmaceutica NV | Lactam-containing imidazopyridazine il-17 inhibitor compounds |
| CN122580300A (zh) | 2024-01-11 | 2026-08-14 | 浙江海正药业股份有限公司 | 磺酰胺类衍生物及其制备方法和用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2711696C (en) | 2008-01-09 | 2021-10-26 | Reza Dana | Therapeutic compositions for treatment of ocular inflammatory disorders |
| EP2809660B1 (en) | 2012-02-02 | 2016-01-20 | Ensemble Therapeutics Corporation | Macrocyclic compounds for modulating il-17 |
| WO2014066726A2 (en) | 2012-10-26 | 2014-05-01 | Ensemble Therapeutics Corporation | Compounds for modulating il-17 |
| GB201709456D0 (en) | 2017-06-14 | 2017-07-26 | Ucb Biopharma Sprl | Therapeutic agents |
| CN111601799B (zh) | 2018-01-15 | 2023-06-09 | Ucb生物制药有限责任公司 | 作为Il-17调节剂的稠合咪唑衍生物 |
| WO2019223718A1 (zh) | 2018-05-22 | 2019-11-28 | 成都先导药物开发股份有限公司 | 一种免疫调节剂 |
| WO2020011731A1 (en) | 2018-07-12 | 2020-01-16 | UCB Biopharma SRL | Spirocyclic indane analogues as il-17 modulators |
| GB201820165D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201820166D0 (en) | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
| MX2021006421A (es) | 2018-12-19 | 2021-08-16 | Leo Pharma As | Anilidas de aminoácidos como moduladores de moléculas pequeñas de interleucinas-17 (il-17). |
| TWI752400B (zh) | 2019-01-07 | 2022-01-11 | 美商美國禮來大藥廠 | Il-17a抑制劑 |
| EP3935051A1 (en) | 2019-03-08 | 2022-01-12 | Leo Pharma A/S | Small molecule modulators of il-17 |
| GB201909190D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909194D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| GB201909191D0 (en) | 2019-06-26 | 2019-08-07 | Ucb Biopharma Sprl | Therapeutic agents |
| KR20230017211A (ko) | 2020-04-30 | 2023-02-03 | 얀센 파마슈티카 엔.브이. | Il-17 경로의 조절인자를 식별하는 방법 |
| JP7664947B2 (ja) | 2020-04-30 | 2025-04-18 | ヤンセン ファーマシューティカ エヌ.ベー. | Il-17の調節因子としてのイミダゾリダジン |
| US20240140951A1 (en) * | 2020-12-14 | 2024-05-02 | UCB Biopharma SRL | Imidazopyridazine derivatives as il-17 modulators |
-
2021
- 2021-12-06 US US18/267,235 patent/US20240140951A1/en active Pending
- 2021-12-06 WO PCT/EP2021/084448 patent/WO2022128584A1/en not_active Ceased
- 2021-12-06 CA CA3200594A patent/CA3200594A1/en active Pending
- 2021-12-06 EP EP21834749.0A patent/EP4259631A1/en active Pending
- 2021-12-06 JP JP2023535832A patent/JP7827725B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024525044A5 (cg-RX-API-DMAC7.html) | ||
| CN101228169B (zh) | 丙型肝炎病毒的大环抑制剂 | |
| CN111278815B (zh) | 戊二酰亚胺 | |
| US10954247B2 (en) | Apelin receptor (APJ) agonists and uses thereof | |
| US11572374B2 (en) | N-cyano-7-azanorbornane derivatives and uses thereof | |
| AU2017343638B2 (en) | Heterocyclic apelin receptor (APJ) agonists and uses thereof | |
| TWI297011B (en) | Dpp-iv inhibitors | |
| RU2339636C2 (ru) | Гексагидропиридоизохинолины в качестве ингибиторов дипептидилпептидазы iv (dpp-iv) | |
| EP2822942B1 (en) | Benzodioxanes for inhibiting leukotriene production | |
| JP4068958B2 (ja) | 免疫抑制剤としてのピロロ(2,3−d)ピリミジン化合物 | |
| EP2590981B1 (en) | Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof | |
| JP2008510006A5 (cg-RX-API-DMAC7.html) | ||
| CN106661017B (zh) | 二环性或三环性杂环化合物 | |
| PT1912997E (pt) | Inibidores macrocíclicos do vírus da hepatite c | |
| RU2002104935A (ru) | ПРОИЗВОДНЫЕ 8-ФЕНИЛ-6,9-ДИГИДРО[1,2,4]ТРИАЗОЛО[3,4-i]ПУРИН-5-ОНА | |
| JP2021523941A5 (cg-RX-API-DMAC7.html) | ||
| US12590099B2 (en) | Inhibitors of histone deacetylase useful for the treatment or prevention of HIV infection | |
| JP5384733B2 (ja) | 6,7−ジヒドロ−5H−イミダゾ[1,2−a]イミダゾール−3−カルボン酸アミドの誘導体 | |
| JP5389917B2 (ja) | ケモカインレセプターのジアゼパン及びピペラジン誘導体モデュレーター | |
| KR101238281B1 (ko) | 효과적인 진통제로서의 (1s,5s)-3-(5,6-디클로로-3-피리디닐)-3,6-디아자비사이클로[3.2.0]헵탄 | |
| JP2007512317A (ja) | ピラゾロピリミジン類 | |
| JP2007532526A (ja) | ピラゾロ[4,3−d]ピリミジン類 | |
| MX2008001404A (en) | Macrocyclic inhibitors of hepatitis c virus |